The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Self-citation(1997) · Obesity Surgery · doi:10.1381/096089297765555359 · Cited by 3,916
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
Geyer, C. E., Forster, J., Lindquist, D., Chan, S., Romieu, C. G., Pienkowski, T., Jagiello-Gruszfeld, A., Crown, J., Chan, A., Kaufman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa064320 · Cited by 3,425
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-18-asocco · Cited by 1,816
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
Joensuu, H., Kellokumpu-Lehtinen, P.-L., Bono, P., Alanko, T., Kataja, V., Asola, R., Utriainen, T., Kokko, R., Hemminki, A., Tarkkanen, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053028 · Cited by 1,403
Concordance among Gene-Expression–Based Predictors for Breast Cancer
Fan, C., Oh, D. S., Wessels, L., Weigelt, B., Nuyten, D. S. A., Nobel, A. B., van't Veer, L. J., & Perou, C. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052933 · Cited by 1,341
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van ’t Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.188 · Cited by 1,171
Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi326 · Cited by 1,127
Self-citationGoss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji250 · Cited by 1,118
Winer, E. P., Hudis, C., Burstein, H. J., Wolff, A. C., Pritchard, K. I., Ingle, J. N., Chlebowski, R. T., Gelber, R., Edge, S. B., Gralow, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.121 · Cited by 1,031
Self-citationCoates, A. S., Keshaviah, A., Thürlimann, B., Mouridsen, H., Mauriac, L., Forbes, J. F., Paridaens, R., Castiglione-Gertsch, M., Gelber, R. D., Colleoni, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8617 · Cited by 910
Self-citationCoombes, R., Kilburn, L., Snowdon, C., Paridaens, R., Coleman, R., Jones, S., Jassem, J., Van de Velde, C., Delozier, T., Alvarez, I., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60200-1 · Cited by 907
Self-citationJakesz, R., Jonat, W., Gnant, M., Mittlboeck, M., Greil, R., Tausch, C., Hilfrich, J., Kwasny, W., Menzel, C., Samonigg, H., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67059-6 · Cited by 879
Recht, A., Edge, S. B., Solin, L. J., Robinson, D. S., Estabrook, A., Fine, R. E., Fleming, G. F., Formenti, S., Hudis, C., Kirshner, J. J., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1539 · Cited by 816
Berry, D. A., Cirrincione, C., Henderson, I. C., Citron, M. L., Budman, D. R., Goldstein, L. J., Martino, S., Perez, E. A., Muss, H. B., Norton, L., et al. (2006) · JAMA · doi:10.1001/jama.295.14.1658 · Cited by 731
Kaufmann, M., Hortobagyi, G. N., Goldhirsch, A., Scholl, S., Makris, A., Valagussa, P., Blohmer, J.-U., Eiermann, W., Jackesz, R., Jonat, W., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.6187 · Cited by 725
Self-citationExtending Survival with Chemotherapy in Metastatic Breast Cancer
O'Shaughnessy, J. (2005) · The Oncologist · doi:10.1634/theoncologist.10-90003-20 · Cited by 668
Bijker, N., Meijnen, P., Peterse, J. L., Bogaerts, J., Van Hoorebeeck, I., Julien, J.-P., Gennaro, M., Rouanet, P., Avril, A., Fentiman, I. S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1366 · Cited by 663
Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
Wood, W. C., Budman, D. R., Korzun, A. H., Cooper, M. R., Younger, J., Hart, R. D., Moore, A., Ellerton, J. A., Norton, L., Ferree, C. R., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301801 · Cited by 577
Self-citationDose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
(1994) · New England Journal of Medicine · doi:10.1056/nejm199407143310226 · Cited by 556
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen
Goetz, M. P., Knox, S. K., Suman, V. J., Rae, J. M., Safgren, S. L., Ames, M. M., Visscher, D. W., Reynolds, C., Couch, F. J., Lingle, W. L., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9428-0 · Cited by 552
Khatcheressian, J. L., Wolff, A. C., Smith, T. J., Grunfeld, E., Muss, H. B., Vogel, V. G., Halberg, F., Somerfield, M. R., & Davidson, N. E. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8575 · Cited by 535
FISHER, B. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90133-2 · Cited by 516
HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
Pritchard, K. I., Shepherd, L. E., O'Malley, F. P., Andrulis, I. L., Tu, D., Bramwell, V. H., & Levine, M. N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054504 · Cited by 509
Ten Genes for Inherited Breast Cancer
Walsh, T., & King, M.-C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.010 · Cited by 477
Osborne, C. K., Shou, J., Massarweh, S., & Schiff, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.865s.11.2 · Cited by 462
Cognitive Impairment Associated With Chemotherapy for Cancer: Report of a Workshop
Tannock, I. F., Ahles, T. A., Ganz, P. A., & van Dam, F. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.094 · Cited by 453
Perez, E. A., Suman, V. J., Davidson, N. E., Martino, S., Kaufman, P. A., Lingle, W. L., Flynn, P. J., Ingle, J. N., Visscher, D., & Jenkins, R. B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4744 · Cited by 438
Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer
Rouzier, R., Rajan, R., Wagner, P., Hess, K. R., Gold, D. L., Stec, J., Ayers, M., Ross, J. S., Zhang, P., Buchholz, T. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408974102 · Cited by 413
Rapiti, E., Verkooijen, H. M., Vlastos, G., Fioretta, G., Neyroud-Caspar, I., Sappino, A. P., Chappuis, P. O., & Bouchardy, C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2226 · Cited by 391
Domchek, S. M., Friebel, T. M., Neuhausen, S. L., Wagner, T., Evans, G., Isaacs, C., Garber, J. E., Daly, M. B., Eeles, R., Matloff, E., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70585-x · Cited by 327
Rodríguez-Pinilla, S. M., Sarrió, D., Honrado, E., Hardisson, D., Calero, F., Benitez, J., & Palacios, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2281 · Cited by 324
Use and outcomes of adjuvant chemotherapy in older women with breast cancer
Giordano, S. H., Duan, Z., Kuo, Y.-F., Hortobagyi, G. N., & Goodwin, J. S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.3028 · Cited by 318
Breast carcinoma during pregnancy: International recommendations from an expert meeting
Loibl, S., von Minckwitz, G., Gwyn, K. M., Ellis, P., Blohmer, J., Schlegelberger, B., Keller, M., Harder, S., Theriault, R. L., Crivellari, D., et al. (2005) · Cancer · doi:10.1002/cncr.21610 · Cited by 307
Babiera, G. V., Rao, R., Feng, L., Meric-Bernstam, F., Kuerer, H. M., Singletary, S. E., Hunt, K. K., Ross, M. I., Gwyn, K. M., Feig, B. W., et al. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.03.033 · Cited by 284
Hershman, D., Neugut, A. I., Jacobson, J. S., Wang, J., Tsai, W.-Y., McBride, R., Bennett, C. L., & Grann, V. R. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk028 · Cited by 279
Bonneterre, J. M., Roche, H. H., Kerbrat, P., Bremond, A. G., Fumoleau, P., Namer, M., Goudier, M.-J., Schraub, S., Fargeot, P., & Chapelle-Marcillac, I. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.059 · Cited by 276
TAILORx: Trial Assigning Individualized Options for Treatment (Rx)
Sparano, J. A. (2006) · Clinical Breast Cancer · doi:10.3816/cbc.2006.n.051 · Cited by 262
Fertility Preservation in Young Women Undergoing Breast Cancer Therapy
Sonmezer, M., & Oktay, K. (2006) · The Oncologist · doi:10.1634/theoncologist.11-5-422 · Cited by 261
Cost-effectiveness of Screening BRCA1/2 Mutation Carriers With Breast Magnetic Resonance Imaging
Plevritis, S. K., Kurian, A. W., Sigal, B. M., Daniel, B. L., Ikeda, D. M., Stockdale, F. E., & Garber, A. M. (2006) · JAMA · doi:10.1001/jama.295.20.2374 · Cited by 260
By the French Adjuvant Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.602 · Cited by 252
Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial
Bogaerts, J., Cardoso, F., Buyse, M., Braga, S., Loi, S., Harrison, J. A., Bines, J., Mook, S., Decker, N., Ravdin, P., et al. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0591 · Cited by 237
Martin, M., Villar, A., Sole-Calvo, A., Gonzalez, R., Massuti, B., Lizon, J., Camps, C., Carrato, A., Casado, A., Candel, M. T., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg260 · Cited by 188
Timolati, F., Ott, D., Pentassuglia, L., Giraud, M.-N., Perriard, J.-C., Suter, T. M., & Zuppinger, C. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.08.002 · Cited by 178
Rakovitch, E., Franssen, E., Kim, J., Ackerman, I., Pignol, J.-P., Paszat, L., Pritchard, K. I., Ho, C., & Redelmeier, D. A. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1021853302033 · Cited by 171
Regan, M. M., Viale, G., Mastropasqua, M. G., Maiorano, E., Golouh, R., Carbone, A., Brown, B., Suurküla, M., Langman, G., Mazzucchelli, L., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj415 · Cited by 164
Self-citationBRCA1, a Potential Predictive Biomarker in the Treatment of Breast Cancer
James, C. R., Quinn, J. E., Mullan, P. B., Johnston, P. G., & Harkin, D. P. (2007) · The Oncologist · doi:10.1634/theoncologist.12-2-142 · Cited by 160
Clarke, C. A., Glaser, S. L., Uratsu, C. S., Selby, J. V., Kushi, L. H., & Herrinton, L. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6504 · Cited by 160
Mauriac, L., Keshaviah, A. P., Debled, M., Mouridsen, H. T., Forbes, J., Thurlimann, B. J. K., Paridaens, R., Monnier, A., Láng, I., Wardley, A. M., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm001 · Cited by 136
Self-citationAdjuvant Breast Cancer Treatment and Cognitive Function: Current Knowledge and Research Directions
Phillips, K., & Bernhard, J. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.190 · Cited by 133
First—select the target: better choice of adjuvant treatments for breast cancer patients
Goldhirsch, A., Coates, A. S., Gelber, R. D., Glick, J. H., Thurlimann, B. J. K., & Senn, H.-J. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl398 · Cited by 97
Self-citationCataliotti, L., de Wolf, C., Holland, R. D., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2006.12.008 · Cited by 95
Molecular Classification of Breast Tumors: Toward Improved Diagnostics and Treatments
Sørlie, T. (2006) · Humana Press eBooks · doi:10.1385/1-59745-165-7:91 · Cited by 91
Demicheli, R., Hrushesky, W. J. M., Retsky, M. W., Bonadonna, G., & Valagussa, P. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9279-2 · Cited by 90
BRCA1 and BRCA2 in breast cancer
Yang, X.-H. R., & Lippman, M. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006189906896 · Cited by 76
Ring, A. E., Smith, I. E., & Ellis, P. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi388 · Cited by 76
Heterogeneity of ductal carcinoma in situ and its effects on management
Mokbel, K., & Cutuli, B. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70861-0 · Cited by 76
Soto, J. A. D., & Deng, C. (2006) · International Journal of Medical Sciences · doi:10.7150/ijms.3.117 · Cited by 71
Barroso, G., Menocal, G., Felix, H., Ruiz, J. C. R., Arslan, M., & Oehninger, S. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.044 · Cited by 54
The evolution of treatment strategies: Aiming at the target
Dinh, P., Sotiriou, C. P., & Piccart, M. J. (2007) · The Breast · doi:10.1016/j.breast.2007.07.032 · Cited by 38
Ariazi, E. A., Lewis-Wambi, J. S., Gill, S. D., Pyle, J. R., Ariazi, J. L., Kim, H. R., Sharma, C. G. N., Cordera, F., Shupp, H. A., Li, T., et al. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.003 · Cited by 24
Targeted Therapy for Metastatic Breast Cancer
Muss, H. B. (2006) · New England Journal of Medicine · doi:10.1056/nejme068260 · Cited by 22
Follow-up care of patients with breast cancer
Tolaney, S. M., & Winer, E. P. (2007) · The Breast · doi:10.1016/j.breast.2007.07.005 · Cited by 22
Adjuvant therapy and thrombosis: How to avoid the problem?
Levine, M. N. (2007) · The Breast · doi:10.1016/j.breast.2007.07.012 · Cited by 20
Application of aromatase inhibitors in endocrine responsive breast cancers
Goss, P. E., & Wu, M. D. (2007) · The Breast · doi:10.1016/j.breast.2007.07.011 · Cited by 10
The evolution of targeted biologic therapies
Sledge, G. W. (2007) · The Breast · doi:10.1016/j.breast.2007.07.002 · Cited by 2
Cited by
(1997) · Obesity Surgery · doi:10.1381/096089297765555359 · Cited by 3,916
Albain, K. S., Barlow, W. E., Shak, S., Hortobagyi, G. N., Livingston, R. B., Yeh, I.-T., Ravdin, P., Bugarini, R., Baehner, F. L., Davidson, N. E., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70314-6 · Cited by 1,407
Goldhirsch, A., Ingle, J. N., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp322 · Cited by 1,374
Self-citationSturgeon, C. M., Duffy, M. J., Stenman, U.-H., Lilja, H., Brünner, N., Chan, D. W., Babaian, R., Bast, R. C., Dowell, B., Esteva, F. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105601 · Cited by 1,129
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
Gnant, M., Mlineritsch, B., Schippinger, W., Luschin-Ebengreuth, G., Pöstlberger, S., Menzel, C., Jakesz, R., Seifert, M., Hubalek, M., Bjelic-Radisic, V., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806285 · Cited by 1,025
Metadata
- Authors
- Goldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 18
- Issue
- 7
- Pages
- 1133-1144
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2156604663
- Cited by
- 944
- References
- 72
- FWCI
- 43.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.